Evidence map›Paper›PMID 40488199›Full record

ReviewFrontiers in neurology2025

Benign paroxysmal positional vertigo a systematic review of the effects of comorbidities.

Haifa Alolayet, Louisa Murdin

Abstract readReview
In one paragraph

Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. [Effect of body mass index on residual dizziness after repositioning in benign paroxysmal positional vertigo].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  4. Recurrence of benign paroxysmal positional vertigo: risk factors and outcomes.Revista da Associacao Medica Brasileira (1992) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Haifa Alolayet *Department of Audiology, Cochlear Implant Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Louisa Murdin *Department of ENT, Guy's and St Thomas NHS Foundation Trust and UCL Ear Institute, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of benign paroxysmal positional vertigo (BPPV) increases with age, as does the occurrence of other chronic health conditions. Although treatment with canalith-repositioning procedures (CRPs) is relatively successful, efficacy on the first attempt varies. Several studies have examined the influence of risk factors on BPPV occurrence and the efficacy of initial CRPs. However, findings are controversial. The objective of this study is to identify comorbidities associated with BPPV occurrence and explore their influence on the success of initial CRPs. Methods: The electronic databases PubMed, Scopus, Web of Science, Embase, MEDLINE and CINAHL were searched to identify eligible English original studies published from January 2019 to June 2024. All search results were reviewed based on our inclusion and exclusion criteria. Results: Of the 463 studies identified, 50 studies that satisfied the inclusion criteria were analysed. Eighteen studies focused on BPPV occurrence, 24 on the initial-CRP outcome and eight on both BPPV occurrence and the initial-CRP outcome. Twenty-five risk factors and comorbidities were identified to be associated with BPPV occurrence, and 15 were noted to impact the efficacy of the initial CRP. The most common reported risk factor for BPPV occurrence was head trauma (16 studies) and showed the poorest success rate after one CRP requiring a maximum of 18 manoeuvres to reach complete resolution (9 studies). Other factors included cardiovascular and endocrine comorbidities, neurological/neurotological comorbidities, musculoskeletal comorbidities, anxiety, obsessive-compulsive disorder, body mass index, serum vitamin D level and idiopathic BPPV. Conclusion: This systematic review assess the strength of evidence of risk factors influencing the development of BPPV and outcome of the initial CRP. Hypertension, hypotension, anaemia, ischaemic heart disease, hyperlipidaemia, stroke, diabetes mellitus, hypothyroidism, migraine, vestibular disorders, peripheral neuropathy, osteoporosis, cervical spondylosis, head trauma and low vitamin D were associated with BPPV incidence. Low levels of vitamin D, head trauma, migraine, inner ear diseases including Ménière's disease, hypertension, high cholesterol, diabetes mellitus, hypothyroidism, hyperlipidaemia, osteoporosis, and reduced cervical mobility are all associated with failed first canal repositioning manoeuvre. There is an identified need to explore risk factors across different BPPV subtypes and their impact on the efficacy of various treatment manoeuvres.

Indexed as

BPPVcomorbidityCRPefficacyoccurrencerisk factors

Identifiers

PMID40488199
PMCPMC12141001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.